Lexaria Bioscience (LEXX) Current Leases (2020 - 2026)
Lexaria Bioscience's (LEXX) quarterly Current Leases came in at $32060.0 in Q1 2026, up 9.28% year-on-year from $29337.0 in Q1 2025, and up 3.08% quarter-over-quarter from $31101.0 in Q4 2025.
Lexaria Bioscience (LEXX) Current Leases (2020 - 2026) Analysis & Trends
Lexaria Bioscience has disclosed Current Leases across 7 years of filings, most recently posting $32060.0 for Q1 2026.
- Current Leases for Q1 2026 came in at $32060.0, up 9.28% year-over-year; the trailing twelve-month figure through Feb 2026 was $32060.0 (up 9.28% YoY), and the FY2025 annual result was $30417.0, up 8.45% from the prior year.
- Current Leases came in at $32060.0 for Q1 2026 at Lexaria Bioscience, up from $31101.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $42587.0 in Q3 2022 to a low of $25554.0 in Q4 2023.
- The 5-year median for Current Leases is $29872.0 (2025), against an average of $31951.0.
- Across the five-year window, Current Leases plunged 35.52% in 2023 and rose 12.75% in 2024, its largest moves.
- Lexaria Bioscience's Current Leases stood at $39629.0 in 2022, then slumped by 35.52% to $25554.0 in 2023, then rose by 12.75% to $28812.0 in 2024, then advanced by 7.94% to $31101.0 in 2025, then grew by 3.08% to $32060.0 in 2026.
- The last three Current Leases figures came in at $32060.0 (Q1 2026), $31101.0 (Q4 2025), and $30417.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Lexaria Bioscience | 7.17 Mn | 1.65 Mn | 20,000.00 | 32,060.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 32,060.00 |
| Nov 30, 2025 | 31,101.00 |
| Aug 31, 2025 | 30,417.00 |
| May 31, 2025 | 29,872.00 |
| Feb 28, 2025 | 29,337.00 |
| Nov 30, 2024 | 28,812.00 |
| Aug 31, 2024 | 28,047.00 |
| May 31, 2024 | 27,260.00 |
| Feb 29, 2024 | 26,399.00 |
| Nov 30, 2023 | 25,554.00 |
| Aug 31, 2023 | 27,794.00 |
| May 31, 2023 | 32,317.00 |
| Feb 28, 2023 | 29,080.00 |
| Nov 30, 2022 | 39,629.00 |
| Aug 31, 2022 | 42,587.00 |
| May 31, 2022 | 41,825.00 |
| Feb 28, 2022 | 41,076.00 |
| Aug 31, 2021 | 39,404.00 |
| May 31, 2021 | 38,485.00 |
| Feb 28, 2021 | 37,582.00 |